J. Safra Sarasin Holding’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.39M	Buy	171,119 +98,447	+135%	+$1.38M	0.04%	191
2025 Q1	$980K	Buy	72,672 +36,219	+99%	+$488K	0.02%	330
2024 Q4	$699K	Buy	+36,453	New	+$699K	0.01%	375